Leptin, a hormone considered critical in body weight regulation and obesity, also might play a role in diabetic eye disease, a study by Yale researchers shows.
Leptin is known to exist in fatty tissue, in the placenta, ovaries, mammary glands, gastric mucosa and liver, as well as other tissues. The Yale study of 73 patients with and without severe diabetic eye disease also found leptin in the eye tissue of patients with diabetic retinopathy.
"We measured the amount of leptin inside the vitreous humor and found leptin was highly elevated in patients with advanced eye disease compared with patients who don't have the disease," says Dr. Ray Gariano, assistant professor of ophthalmology at the School of Medicine. His study was published in the journal Investigative Ophthalmology & Visual Science.
A coauthor of the study, Dr. Maria Rocio Sierra-Honigmann, formerly an associate research scientist in the pathology department at Yale, discovered a few years ago that leptin causes blood vessels to grow.
"We hypothesized that perhaps leptin is involved in diabetic eye disease since abnormal blood vessel growth occurs in more advanced stages of diabetic eye disease," says Gariano. "Our results support that proposition."
The research group found that leptin was highest in the group of patients with proliferative retinopathy; intermediate in the group with primary or recurrent retinal detachment, and lowest in the group with mild diabetic retinopathy or a variety of non-diabetic eye diseases.
Gariano says it is not yet clear how this finding could be used to minimize severe eye disease in diabetics since there are currently no drugs that inhibit leptin or block its actions.
Leptin regulates body weight, promotes satiety, decreases appetite, decreases the degree to which the body synthesizes fat and increases the body's ability to burn fat. Like diabetics who have a surplus of insulin that their bodies fail to secrete properly, some people who are overweight or obese may have a surplus of leptin that is not functional in regulating body weight, say the researchers.
"Finding a drug to inhibit leptin is a major challenge in obesity research," Gariano says. "But there are some other techniques being tried to inhibit or antagonize leptin's actions, which could be therapeutically beneficial for the eye."
-- By Jacqueline Weaver
T H I S
Bulletin Home
W E E K ' SS T O R I E S
$5 million will fund hypoglycemia study
Peabody to launch program on biodiversity and human health
Albee applauds 'dangerous' dramas
Trio of sisters harmonizing at School of Music
Yale College Dean's Office announces new staff
ENDOWED PROFESSORSHIPSGrigoriy Margulis is named the Erastus L. DeForest Professor of Mathematics
Steven A. Orszag, the new Percey F. Smith Professor of Mathematics . . .
Scientists from Yale, China enter new partnership
Tufte will talk about design 'In the Company of Scholars'
Gordon Grand Fellowship hosts visit by marketing expert
MEDICAL SCHOOL NEWSIntrafallopian tube fertilization is more risky, say researchers
Study: Melatonin is not useful in fighting jet lag
Research reveals leptin's role in diabetic eye disease
Nicotine receptors shown to play key role in Alzheimer's
Globalization brings ethical responsibilities, philosopher says
Exhibit illustrates the connections between Yale, the rail and sports
Junior faculty members will pursue research on fellowships
Yale licenses researchers' new technology for screening ion-channel drugs
The custom of arming slaves to be explored in major conference
Oscar-winning alumna
Possession by dybbuk to be explored in Slifka talk
Scholar is honored for linking biblical stories with ancient societies' social ecology
Linda Schwartz honored for her 'selfless service' on behalf of veterans
Concerts will feature early sacred music
Remington to discuss new book on Darwin
Splendor on the Grass
In the News
Yale Scoreboard
|Visiting on Campus|
Calendar of Events|Bulletin Board
Classified Ads|Search Archives|Production Schedule|Bulletin Staff
Public Affairs Home|News Releases|
E-Mail Us|Yale Home Page